Detalhe da pesquisa
1.
TCRαß/CD19 cell-depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis.
Blood
; 143(3): 279-289, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738655
2.
CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
Blood
; 143(17): 1738-1751, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215390
3.
FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.
Cytometry A
; 105(1): 24-35, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37776305
4.
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature
; 562(7727): 373-379, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209392
5.
CD72 is a pan-tumor antigen associated to pediatric acute leukemia.
Cytometry A
; 103(12): 1004-1009, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37876342
6.
Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
Blood
; 138(7): 557-570, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010415
7.
Molecular characterization and clinical outcome of B-cell precursor acute lymphoblastic leukemia with IG-MYC rearrangement.
Haematologica
; 108(3): 717-731, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35484682
8.
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high-risk first relapse B-cell precursor acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 69(8): e29715, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35482538
9.
Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual disease.
Br J Haematol
; 193(3): 602-612, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715150
10.
CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring CBFA2T3-GLIS2 fusion transcript.
Cytometry A
; 99(8): 844-850, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33811445
11.
Low-Blood Lymphocyte Number and Lymphocyte Decline as Key Factors in COPD Outcomes: A Longitudinal Cohort Study.
Respiration
; 100(7): 618-630, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33902057
12.
Unrelated donor vs HLA-haploidentical α/ß T-cell- and B-cell-depleted HSCT in children with acute leukemia.
Blood
; 132(24): 2594-2607, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30348653
13.
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.
Blood
; 132(3): 264-276, 2018 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720486
14.
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols.
Haematologica
; 105(7): 1887-1894, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601692
15.
Next-generation sequencing of PTEN mutations for monitoring minimal residual disease in T-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 67(1): e28025, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31571345
16.
Flow-cytometric minimal residual disease monitoring in blood predicts relapse risk in pediatric B-cell precursor acute lymphoblastic leukemia in trial AIEOP-BFM-ALL 2000.
Pediatr Blood Cancer
; 66(5): e27590, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561169
17.
The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols.
Br J Haematol
; 182(5): 705-711, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938780
18.
Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia.
Br J Haematol
; 180(5): 680-693, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29359790
19.
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.
Blood
; 137(14): 1980-1984, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512459
20.
Prognostic significance of flow-cytometry evaluation of minimal residual disease in children with acute myeloid leukaemia treated according to the AIEOP-AML 2002/01 study protocol.
Br J Haematol
; 177(1): 116-126, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28240765